Estimation of efficiency and tolerance of treatment with atorvastatin of the patients with ischemic heart disease
The analysis of efficiency and tolerance of treatment of 33 outpatients with ischemic heart disease in the age of 55,8±2,6 years a modern preparation from group statins atorvastatin(tulip), carried out within the limits of the open research. It is shown, that target level Ch. LPLD of 10-20 mg/day will reach in 72,7% cases for 6 months of therapy with use of a doze.